CURIS INC CRIS (NASDAQ) $ 0.78 Change: -0.02 -2.56% | Volume: 251,004
Sponsored by Click here!

CURIS INC - Fundamental Profile

Company Information

Ticker Symbol: CRIS
Exchange: NASD
Contact Info: 45 Moulton Street Cambridge MA 02138 617 503-6500
CEO/President: Daniel R. Passeri
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis\' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.

Share Information

Shares Outstanding: 63,430 (000) Market Value: 50,750 ($000)
Percentage of Inst.Shareholders: 50.87% Number of Inst.Shareholders: 9.06%
Last Quarter Sales: 0.09 ($Mil.) Last Quarter Net Income: -4.57 ($Mil.)
Last Quarter EPS: -0.07 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.08
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41